Influenza A virus H5N1 hemagglutinin protein (HA) (HA)

Influenza A virus H5N1 hemagglutinin (HA) is a critical homotrimeric surface glycoprotein that mediates the initial stages of viral infection. It functions by binding to sialic acid receptors on the host cell surface; specifically, H5N1 HA has a high affinity for alpha-2,3-linked sialic acids, which are common in birds and the human lower respiratory tract (UniProt, 2024). Following attachment and subsequent endocytosis, the acidic environment of the endosome induces a dramatic conformational change in the HA protein, particularly the HA2 subunit, which facilitates the fusion of the viral envelope with the host cell membrane (NCBI, 2023). This fusion process is essential for releasing the viral ribonucleoproteins into the host cytoplasm for replication. As the primary target for the host's neutralizing antibody response, HA is the central component of H5N1 vaccines and a major focus for the development of broad-spectrum monoclonal antibodies (PubMed, 2022). However, the high mutation rate of the HA gene allows the virus to undergo antigenic drift, necessitating continuous monitoring and the development of next-generation vaccines to mitigate the risk of a global pandemic (WHO, 2024).

Other names

HemagglutininH5 HAHA1/HA2 complexSurface glycoproteinH5N1 HA

Inhibition of viral entry by blocking the binding of the hemagglutinin protein to host sialic acid receptors or by preventing the pH-dependent conformational change required for membrane fusion (PubMed, 2022).